---
title: AustinPx vs Crystec Limited (CrystecPharma)
slug_a: austinpx
slug_b: crystecpharma
site: cdmo
review_signal_gate: closed
canonical_path: /compare/austinpx/crystecpharma
---

# AustinPx vs Crystec Limited (CrystecPharma)

Side-by-side profile data from each company listing on this directory.

## AustinPx

- Profile: [/companies/austinpx](/companies/austinpx)

AustinPx — Fee-for-service CDMO specializing in formulation development, process development, and GMP manufacturing of oral dosage forms from preclinical through Phase II, with proprietary KinetiSol amorphous solid dispersion technology for poorly soluble APIs.

Services: 7. Modalities: 1. Indications: 0. Locations: 2. Certifications: 0. The strongest documented coverage currently appears in services (7).

### Services

- Analytical Method Development & Validation
- ICH Stability Studies
- Solid-State Chemistry & Polymorph Screening
- Oral Solid Dosage Manufacturing
- Process Development
- Formulation Development
- CMC Analytical Development

### Modalities

- Small Molecule

### Development capabilities

- Analytical method development
- Formulation development
- Solid-state characterization

### Manufacturing capabilities

- Drug Substance (DS)
- Drug Product (DP)
- Oral Solid Dose (OSD)

## Crystec Limited (CrystecPharma)

- Profile: [/companies/crystecpharma](/companies/crystecpharma)

Crystec Limited (CrystecPharma) — Crystec Limited (CrystecPharma) is a pharmaceutical technology company that offers its mSAS® supercritical-fluid particle engineering platform to improve the bioavailability, stability and delivery of small and large molecule therapeutics. Its work is aimed at clients developing new and existing medicines.

Services: 4. Modalities: 5. Indications: 1. Locations: 4. Certifications: 0. The strongest documented coverage currently appears in modalities (5).

### Services

- Solid-State Chemistry & Polymorph Screening
- Inhalation & Nasal Dosage Manufacturing
- Process Development
- Formulation Development

### Modalities

- Small Molecule
- Biologics (Monoclonal Antibodies)
- Biologics (Other)
- Oligonucleotide
- Peptide

### Development capabilities

- Formulation development

### Manufacturing capabilities

- Data not yet provided.